Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors.
Xu D, Li N, He Y, Timofeyev V, Lu L, Tsai HJ, Kim IH, Tuteja D, Mateo RK, Singapuri A, Davis BB, Low R, Hammock BD, Chiamvimonvat N.
Xu D, et al. Among authors: singapuri a.
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18733-8. doi: 10.1073/pnas.0609158103. Epub 2006 Nov 27.
Proc Natl Acad Sci U S A. 2006.
PMID: 17130447
Free PMC article.